person · Reporting owner
Quiroga Cortes Isidoro Alfonso
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
FTC Solar, Inc.
Report date August 19, 2024 · Filed August 21, 2024
Section 16 reporting ended · disclosed 2024-08-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,441,740 |
Ending reported balance
After 2024-08-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-08-19 · Purchase · Acquired 160,000 · Balance 2,411,740 F1: Represents a weighted average purchase price per share for these shares, which were purchased in multiple transactions at prices ranging from $0.243 to $0.254. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Row 2 · 2024-08-20 · Purchase · Acquired 30,000 · Balance 2,441,740 F2: Represents a weighted average purchase price per share for these shares, which were purchased in multiple transactions at prices ranging from $0.250 to $0.270. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a weighted average purchase price per share for these shares, which were purchased in multiple transactions at prices ranging from $0.243 to $0.254. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2: Represents a weighted average purchase price per share for these shares, which were purchased in multiple transactions at prices ranging from $0.250 to $0.270. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
Rani Therapeutics Holdings, Inc.
Report date November 24, 2023 · Filed December 08, 2023
Jointly reported with Aequanimitas Limited Partnership
Section 16 reporting ended · disclosed 2023-12-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectShares indirectly held through Aequanimitas Limited Partnership | 8,400 |
Reported balance
After 2023-11-24 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2023-11-24 · Sale · Disposed 5,265,165 · Balance 8,400 F1: The Reporting Person sold 5,265,165 shares of the Issuer's Class A Common Stock in a private secondary offering that was priced at the prevailing market price. F2: Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas Limited Partnership ("Aequanimitas") as its general partner with the power to manage Aequanimitas. Quiroga Cortes is the sole limited partner of Aequanimitas. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person sold 5,265,165 shares of the Issuer's Class A Common Stock in a private secondary offering that was priced at the prevailing market price.
F2: Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas Limited Partnership ("Aequanimitas") as its general partner with the power to manage Aequanimitas. Quiroga Cortes is the sole limited partner of Aequanimitas.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2024 Filed Aug 21, 2024 08:00 UTC | FTC Solar, Inc. FTCI · Entity 7353 | PurchaseCommon Stock | 30,000 | $0.26 | $7,800.00 |
DisclosureSEC source: 0000950170-24-099390 · ownership.xml · nonDerivative · entry 2 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,441,740 F2 · price: Represents a weighted average purchase price per share for these shares, which were purchased in multiple transactions at prices ranging from $0.250 to $0.270. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| August 19, 2024 Filed Aug 21, 2024 08:00 UTC | FTC Solar, Inc. FTCI · Entity 7353 | PurchaseCommon Stock | 160,000 | $0.25 | $40,000.00 |
DisclosureSEC source: 0000950170-24-099390 · ownership.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,411,740 F1 · price: Represents a weighted average purchase price per share for these shares, which were purchased in multiple transactions at prices ranging from $0.243 to $0.254. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 08:00 UTC | FTC Solar, Inc. FTCI · Entity 7353 | PurchaseCommon Stock | 200,000 | $0.25 | $50,000.00 |
DisclosureSEC source: 0000950170-24-098857 · ownership.xml · nonDerivative · entry 2 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,251,740 F2 · price: Represents a weighted average purchase price per share for these shares, which were purchased in multiple transactions at prices ranging from $0.235 to $0.260. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 08:00 UTC | FTC Solar, Inc. FTCI · Entity 7353 | PurchaseCommon Stock | 3,952 | $0.26 | $1,027.52 |
DisclosureSEC source: 0000950170-24-097813 · ownership.xml · nonDerivative · entry 2 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,945,692 Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 08:00 UTC | FTC Solar, Inc. FTCI · Entity 7353 | PurchaseCommon Stock | 106,048 | $0.24 | $25,451.52 |
DisclosureSEC source: 0000950170-24-098857 · ownership.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,051,740 F1 · price: Represents a weighted average purchase price per share for these shares, which were purchased in multiple transactions at prices ranging from $0.239 to $0.250. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 08:00 UTC | FTC Solar, Inc. FTCI · Entity 7353 | PurchaseCommon Stock | 321,337 | $0.25 | $80,334.25 |
DisclosureSEC source: 0000950170-24-097813 · ownership.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,941,740 F1 · price: Represents a weighted average purchase price per share for these shares, which were purchased in multiple transactions at prices ranging from $0.240 to $0.260. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| August 13, 2024 Filed Aug 15, 2024 08:00 UTC | FTC Solar, Inc. FTCI · Entity 7353 | PurchaseCommon Stock | 40,000 | $0.22 | $8,800.00 |
DisclosureSEC source: 0000950170-24-097370 · ownership.xml · nonDerivative · entry 2 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,620,403 Read SEC document |
| August 12, 2024 Filed Aug 15, 2024 08:00 UTC | FTC Solar, Inc. FTCI · Entity 7353 | PurchaseCommon Stock | 500,000 | $0.22 | $110,000.00 |
DisclosureSEC source: 0000950170-24-097370 · ownership.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,580,403 F1 · price: Represents a weighted average purchase price per share for these shares, which were purchased in multiple transactions at prices ranging from $0.216 to $0.225. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 16:30 UTC | FTC Solar, Inc. FTCI · Entity 7353 | GrantCommon Stock | 90,450 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-071337 · ownership.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,080,403 F1 · shares: Reflects an annual grant of restricted stock units pursuant to the Issuer's 2021 Stock Incentive Plan in consideration of the Reporting Person's service on the board of directors (BOD) of the Issuer, and is subject to vesting upon the earlier of (x) the one year anniversary of grant and (y) the Issuer's 2025 shareholder meeting, subject to continued service on the BOD. Read SEC document |
| November 24, 2023 Filed Dec 8, 2023 16:29 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | SaleClass A Common Stock | 5,265,165 | $2.01 | $10,582,981.65 |
DisclosureSEC source: 0001104659-23-124723 · tm2332512-1_4seq1.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · 10% owner Aequanimitas Limited Partnership · CIK 0001953625 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through Aequanimitas Limited Partnership Disclosed balance after: 8,400 F1 · kind: The Reporting Person sold 5,265,165 shares of the Issuer's Class A Common Stock in a private secondary offering that was priced at the prevailing market price. F2 · ownership.nature: Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas Limited Partnership ("Aequanimitas") as its general partner with the power to manage Aequanimitas. Quiroga Cortes is the sole limited partner of Aequanimitas. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 16:30 UTC | FTC Solar, Inc. FTCI · Entity 7353 | GrantCommon Stock | 57,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034317 · doc4.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 989,953 F1 · shares: Reflects an annual grant of restricted stock units pursuant to the Issuer's 2021 Stock Incentive Plan in consideration of the Reporting Person's service on the board of directors (BOD) of the Issuer, and is subject to vesting upon the earlier of (x) the one year anniversary of grant and (y) the Issuer's 2024 shareholder meeting, subject to continued service on the BOD. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:31 UTC | FTC Solar, Inc. FTCI · Entity 7353 | GrantCommon Stock | 17,487 | $2.86 | $50,012.82 |
DisclosureSEC source: 0001209191-23-015526 · doc4.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 932,399 F1 · price: Reflects a grant of restricted stock units, which vested in full upon grant, pursuant to the Issuer's 2021 Stock Incentive Plan made to the Reporting Person in lieu of the annual cash compensation otherwise payable to the Reporting Person for his service on the board of directors of the Issuer. The number of restricted stock units was determined by dividing the amount of such annual cash compensation by the thirty (30) day volume weighted average price (VWAP) of the Issuer's common stock as of the date of grant. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 20:06 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 8,400 | $6.03 | $50,616.72 |
DisclosureSEC source: 0001104659-23-000497 · tm2231865-8_4seq1.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · 10% owner Aequanimitas Limited Partnership · CIK 0001953625 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through Aequanimitas Limited Partnership Disclosed balance after: 5,271,378 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.84 to $6.20 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · ownership.nature: Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas Limited Partnership ("Aequanimitas") as its general partner with the power to manage Aequanimitas. Quiroga Cortes is the sole limited partner of Aequanimitas. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 17:06 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 15,192 | $6.90 | $104,794.42 |
DisclosureSEC source: 0001104659-22-115484 · tm2229846-1_4seq1.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · 10% owner Aequanimitas Limited Partnership · CIK 0001953625 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through Aequanimitas Limited Partnership Disclosed balance after: 5,262,978 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.42 to $7.00 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · ownership.nature: Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas Limited Partnership ("Aequanimitas") as its general partner with the power to manage Aequanimitas. Quiroga Cortes is the sole limited partner of Aequanimitas. Read SEC document |
| November 02, 2022 Filed Nov 2, 2022 19:41 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 25,197 | $6.31 | $158,955.27 |
DisclosureSEC source: 0001104659-22-114089 · tm2229549-1_4seq1.xml · nonDerivative · entry 3 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through Aequanimitas Limited Partnership Disclosed balance after: 5,247,786 F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.01 to $6.50 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas Limited Partnership ("Aequanimitas") as its general partner with the power to manage Aequanimitas. Quiroga Cortes is the sole limited partner of Aequanimitas. Read SEC document |
| November 02, 2022 Filed Nov 7, 2022 17:08 UTC Amendment | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 25,197 | $6.31 | $158,955.27 |
DisclosureSEC source: 0001104659-22-115487 · tm2229846-2_4aseq1.xml · nonDerivative · entry 3 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · 10% owner Aequanimitas Limited Partnership · CIK 0001953625 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through Aequanimitas Limited Partnership Disclosed balance after: 5,247,786 F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.01 to $6.50 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F1 · ownership.nature: This amendment to Isidoro Alfonso Quiroga Cortes' Form 4, originally filed with the SEC on November 2, 2022 (the "Original Form 4"), is being filed to include Aequanimitas Limited Partnership ("Aequanimitas") as a Reporting Person under the Original Form 4. F5 · ownership.nature: Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas as its general partner with the power to manage Aequanimitas. Isidoro Alfonso Quiroga Cortes is the sole limited partner of Aequanimitas. Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 19:41 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 3,768 | $5.98 | $22,533.39 |
DisclosureSEC source: 0001104659-22-114089 · tm2229549-1_4seq1.xml · nonDerivative · entry 2 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through Aequanimitas Limited Partnership Disclosed balance after: 5,222,589 F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.96 to $6.22 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas Limited Partnership ("Aequanimitas") as its general partner with the power to manage Aequanimitas. Quiroga Cortes is the sole limited partner of Aequanimitas. Read SEC document |
| November 01, 2022 Filed Nov 7, 2022 17:08 UTC Amendment | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 3,768 | $5.98 | $22,533.39 |
DisclosureSEC source: 0001104659-22-115487 · tm2229846-2_4aseq1.xml · nonDerivative · entry 2 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · 10% owner Aequanimitas Limited Partnership · CIK 0001953625 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through Aequanimitas Limited Partnership Disclosed balance after: 5,222,589 F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.96 to $6.22 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F1 · ownership.nature: This amendment to Isidoro Alfonso Quiroga Cortes' Form 4, originally filed with the SEC on November 2, 2022 (the "Original Form 4"), is being filed to include Aequanimitas Limited Partnership ("Aequanimitas") as a Reporting Person under the Original Form 4. F5 · ownership.nature: Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas as its general partner with the power to manage Aequanimitas. Isidoro Alfonso Quiroga Cortes is the sole limited partner of Aequanimitas. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 19:41 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 16,523 | $6.11 | $100,977.01 |
DisclosureSEC source: 0001104659-22-114089 · tm2229549-1_4seq1.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through Aequanimitas Limited Partnership Disclosed balance after: 5,218,821 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.98 to $6.14 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. F4 · ownership.nature: Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas Limited Partnership ("Aequanimitas") as its general partner with the power to manage Aequanimitas. Quiroga Cortes is the sole limited partner of Aequanimitas. Read SEC document |
| October 31, 2022 Filed Nov 7, 2022 17:08 UTC Amendment | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 16,523 | $6.11 | $100,977.01 |
DisclosureSEC source: 0001104659-22-115487 · tm2229846-2_4aseq1.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · 10% owner Aequanimitas Limited Partnership · CIK 0001953625 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through Aequanimitas Limited Partnership Disclosed balance after: 5,218,821 F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.98 to $6.14 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. F1 · ownership.nature: This amendment to Isidoro Alfonso Quiroga Cortes' Form 4, originally filed with the SEC on November 2, 2022 (the "Original Form 4"), is being filed to include Aequanimitas Limited Partnership ("Aequanimitas") as a Reporting Person under the Original Form 4. F5 · ownership.nature: Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas as its general partner with the power to manage Aequanimitas. Isidoro Alfonso Quiroga Cortes is the sole limited partner of Aequanimitas. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 16:30 UTC | FTC Solar, Inc. FTCI · Entity 7353 | GrantCommon Stock | 35,794 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-023571 · doc4.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 914,912 F1 · price: The Reporting Person received this annual grant of securities from the Issuer in respect of his service on the board of directors of the Issuer. Read SEC document |
| June 10, 2022 Filed Jun 13, 2022 08:30 UTC | FTC Solar, Inc. FTCI · Entity 7353 | PurchaseCommon Stock | 28,400 | $5.23 | $148,532.00 |
DisclosureSEC source: 0000899243-22-022073 · doc4.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 879,118 F1 · price: Represents a weighted average purchase price per share for these shares, which were acquired in multiple transactions at prices ranging from $5.180 to $5.270. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Commission or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the range. Read SEC document |
| May 19, 2021 Filed May 21, 2021 16:53 UTC | FTC Solar, Inc. FTCI · Entity 7353 | GrantCommon Stock | 30,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034964 · doc4.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850,718 F1 · price: The Reporting Person received this grant of securities from the Issuer in respect of his/her service on the board of directors of the Issuer. Read SEC document |
| April 30, 2021 Filed May 4, 2021 17:28 UTC | FTC Solar, Inc. FTCI · Entity 7353 | OtherCommon Stock | 140,787 | $12.16 | $1,711,265.99 |
DisclosureSEC source: 0001209191-21-029979 · doc4.xml · nonDerivative · entry 1 Quiroga Cortes Isidoro Alfonso · CIK 0001854578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 819,950 F1 · kind: On April 30, 2021 the Issuer used a portion of the net proceeds from the closing of its initial public offering ("IPO") of Common Stock to purchase Common Stock from certain of the Issuer's pre-IPO equityholders, including the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.